Insider Transactions in Q4 2021 at Cv Rx, Inc. (CVRX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
John Brintnall CHIEF STRATEGY OFFICER AND SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,550
+19.62%
|
$0
$0.24 P/Share
|
|
Dec 28
2021
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,080
+13.71%
|
$0
$0.24 P/Share
|
|
Nov 30
2021
|
Joseph P Slattery |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+25.96%
|
$0
$0.24 P/Share
|
|
Nov 24
2021
|
Dean Bruhn Ding VP OF REG. AFFAIRS AND QA |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+41.61%
|
$0
$0.24 P/Share
|
|
Nov 22
2021
|
Nadim Yared CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,006
+50.0%
|
$0
$0.24 P/Share
|
|
Nov 19
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
300
+9.68%
|
$3,900
$13.69 P/Share
|
|
Nov 18
2021
|
Mudit K. Jain |
BUY
Open market or private purchase
|
Direct |
875
+25.93%
|
$12,250
$14.63 P/Share
|